Clinical research course
Requirements of Phase IV Trials vs. Phase III Trials
What happens after a drug reaches the market? Phase IV trials – also known as Real-World Evidence (RWE) studies – reveal how treatments perform in everyday practice, beyond the controlled setting of earlier phases.
Dates and booking
Choose your date.
No dates are scheduled right now. Join the waiting list below, ask us about the next session, or ask about an in-house course for your team.
Join the waiting list
Leave your details and we will email you as soon as new dates are published. No commitment.
Who it’s for
Is this course for you?
This course is designed for professionals involved in clinical research and development who want a clear understanding of Phase IV trials and Real-World Evidence. It will be especially relevant for:
-
Clinical research associates and project managers
-
Medical affairs and market access professionals
-
Regulatory and pharmacovigilance staff
-
Anyone looking to broaden their knowledge of how medicines are studied post-approval
What you’ll learn
About this course.
Course Description
Phase IV trials, or Real-World Evidence (RWE) studies, provide essential insights into how medicines perform outside the controlled setting of Phase III trials. They highlight effectiveness, safety, and patient outcomes in routine practice, making them increasingly important for both regulators and healthcare decision-makers.
In this focused 2-hour session, you will:
-
Understand the purpose of Phase IV studies and how they differ from earlier phases.
-
Explore the main methods of collecting real-world data, such as registries and electronic health records.
-
Review practical examples of Phase IV trials, learning from both successes and challenges.
-
Discuss the implications of RWE for your own role and projects.
By the end, you will have a clear overview of where Phase IV fits into the clinical research landscape and how to approach these studies with greater confidence.
Learning objectives
After completing this short course, participants will be able to:
-
Explain the purpose and significance of Phase IV (RWE) studies
-
Recognise the differences between earlier clinical phases and Phase IV
-
Identify common approaches to collecting real-world data
-
Reflect on practical examples to apply key takeaways in their own context
Programme highlights
- Introduction to Real-World Evidence (RWE) and its role in clinical research
-
Key differences between Phase III and Phase IV trials
-
Practical examples of Phase IV studies and lessons learned
-
Open discussion on challenges and implications for participants’ work
Good to know
Questions about this course.
Can I book for several colleagues?
Yes. Choose the number of participants next to a date. For a group of 4 or more, an in-house session tailored to your SOPs may suit you better.
What if I need to cancel?
Cancelling more than 30 calendar days before the course is free of charge. Between 21 and 30 days before, 50% of the fee is due, and the full fee within 21 days. A €50 administration fee applies per cancellation. You can also send a colleague in your place by letting us know in writing.
